Clinical Trial Update: N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of intravenous N-acetylcysteine with cisplatin and paclitaxel for ovarian cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• N-acetylcysteine (N-acetylcysteine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Ovarian Carcinoma, Stage 3 or 4, Epithelial Ovarian Carcinoma | Phase 1 | Status: WITHDRAWN